Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-3,058
Closed -$620K 155
2018
Q3
$620K Buy
3,058
+13
+0.4% +$2.54K 0.28% 97
2018
Q2
$559K Buy
3,045
+5
+0.2% +$891 0.26% 102
2018
Q1
$514K Buy
3,040
+3
+0.1% +$539 0.25% 99
2017
Q4
$548K Buy
3,037
+237
+8% +$40.7K 0.26% 102
2017
Q3
$445K Buy
2,800
+4
+0.1% +$625 0.26% 97
2017
Q2
$424 Sell
2,796
-226
-7% -$31.9K 0.22% 85
2017
Q1
$385K Buy
+3,022
New +$379K 0.2% 110
2015
Q2
$439K Buy
+3,443
New +$393K 0.27% 86
2013
Q4
Sell
-5,003
Closed -$320K 168
2013
Q3
$320K Buy
5,003
+1,018
+26% +$65.3K 0.13% 144
2013
Q2
$253K Buy
+3,985
New +$234K 0.11% 152

Other funds holding AET

FMA Advisory's AET Position: Q4 2018 in Review

FMA Advisory sold out of Aetna Inc (AET) in Q4 2018, closing a stake of 3,058 shares — an estimated $620K sold.

FMA Advisory first reported a position in AET in Q2 2013 and held it in 10 quarters. The position peaked at $620K in Q3 2018. 6 funds tracked by Wall St. Rank hold AET as of Q4 2018.

  • FMA Advisory reported no remaining Aetna Inc position as of Q4 2018 after selling out during the quarter.
  • FMA Advisory sold 3,058 Aetna Inc shares in Q4 2018, an estimated $620K.
  • FMA Advisory first reported a position in Aetna Inc in Q2 2013 and held it in 10 quarters.
  • FMA Advisory's Aetna Inc position peaked at $620K in Q3 2018.
  • 6 funds tracked by Wall St. Rank held Aetna Inc as of Q4 2018.

Based on FMA Advisory's 13F filing for Q4 2018, filed 12 Apr 2021.